Related Experiment Videos
Thrombolytic therapy in acute MI. Weighing the risks and benefits
1Department of Internal Medicine, University of Texas Health Science Center, Houston.
Postgraduate Medicine
|December 1, 1990
Abstract:
The underlying cause of acute myocardial infarction can now be effectively treated with thrombolytic agents, thereby increasing myocardial salvage and reducing mortality. Clinicians should always be aware of the risk-to-benefit ratio in treating patients with thrombolytic agents and treat each patient on an individual basis.